Ileal Bile Acid Transporter Inhibitor [EPC]

Ileal Bile Acid Transporter Inhibitor [EPC] was reported 455 times

Drugs of the Ileal Bile Acid Transporter Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 2 0.1429
1 BILE ACIDS INCREASED 20 0.1130
2 EXTRA-AXIAL HAEMORRHAGE 1 0.0588
3 BILE ACIDS ABNORMAL 1 0.0455
4 POOR SCHOOL ATTENDANCE 1 0.0400
5 ADENOVIRAL UPPER RESPIRATORY INFECTION 1 0.0345
6 CHOLESTATIC PRURITUS 1 0.0312
7 MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED 1 0.0256
8 GASTROENTERITIS ASTROVIRAL 2 0.0250
9 STAPHYLOCOCCAL IMPETIGO 1 0.0175
10 OVERFLOW DIARRHOEA 1 0.0125
11 LEUKODYSTROPHY 1 0.0108
12 VITAMIN K DECREASED 1 0.0106
13 GAMMA-GLUTAMYLTRANSFERASE DECREASED 2 0.0104
14 LIVER TRANSPLANT 36 0.0099
15 TOTAL BILE ACIDS INCREASED 1 0.0068
16 HYPOVITAMINOSIS 8 0.0060
17 ANAL INJURY 1 0.0058
18 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
19 WITHDRAWAL HYPERTENSION 1 0.0050
20 STOMA SITE DISCOMFORT 1 0.0044
21 INCREASED INSULIN REQUIREMENT 1 0.0042
22 HYPONATRAEMIC SEIZURE 1 0.0039
23 GONORRHOEA 1 0.0037
24 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
25 BILE ACID MALABSORPTION 1 0.0035
26 HEPATIC CANCER RECURRENT 1 0.0035
27 COAGULATION TIME ABNORMAL 1 0.0033
28 LIVER OPERATION 1 0.0032
29 STOMA CLOSURE 1 0.0032
30 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
31 BILIRUBIN CONJUGATED INCREASED 6 0.0026
32 VITAMIN K DEFICIENCY 1 0.0025
33 CHOLESTASIS OF PREGNANCY 1 0.0022
34 PRIMARY BILIARY CHOLANGITIS 1 0.0021
35 METAPLASIA 1 0.0021
36 PRODUCT DOSAGE FORM ISSUE 1 0.0021
37 HYPERSPLENISM 1 0.0020
38 POST PROCEDURAL DIARRHOEA 1 0.0020
39 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
40 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
41 ENTERAL NUTRITION 1 0.0017
42 TRANSAMINASES ABNORMAL 1 0.0017
43 BLOOD BILIRUBIN DECREASED 1 0.0016
44 POST PROCEDURAL INFLAMMATION 1 0.0016
45 HYPERCHLORAEMIA 1 0.0016
46 BLOOD BILIRUBIN ABNORMAL 2 0.0016
47 SCLERAL DISCOLOURATION 1 0.0015
48 FOETAL HYPOKINESIA 1 0.0014
49 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
50 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
51 PRODUCT INEFFECTIVE 1 0.0013
52 CROUP INFECTIOUS 1 0.0013
53 BLOOD FIBRINOGEN INCREASED 1 0.0013
54 ENTEROVIRUS INFECTION 1 0.0012
55 COLOUR BLINDNESS 1 0.0011
56 INTUSSUSCEPTION 1 0.0010
57 ILEAL ULCER 1 0.0010
58 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
59 STRESS AT WORK 1 0.0009
60 CARBON DIOXIDE DECREASED 1 0.0009
61 BLOOD BILIRUBIN INCREASED 22 0.0008
62 OBSTRUCTION GASTRIC 1 0.0008
63 ADJUSTMENT DISORDER 1 0.0008
64 DIABETIC FOOT INFECTION 1 0.0007
65 INVESTIGATION ABNORMAL 1 0.0007
66 VOMITING PROJECTILE 2 0.0007
67 PORTAL HYPERTENSION 2 0.0006
68 TESTICULAR PAIN 2 0.0006
69 TRANSAMINASES INCREASED 14 0.0006
70 TYMPANIC MEMBRANE PERFORATION 1 0.0006
71 ACUTE SINUSITIS 1 0.0006
72 AORTIC VALVE STENOSIS 1 0.0006
73 JAUNDICE 15 0.0006
74 PRODUCT RESIDUE PRESENT 3 0.0006
75 DYSENTERY 1 0.0005
76 UNDERWEIGHT 1 0.0005
77 EAR HAEMORRHAGE 1 0.0005
78 CHOLANGITIS SCLEROSING 1 0.0005
79 ANAL PRURITUS 1 0.0005
80 OCULAR ICTERUS 2 0.0005
81 MIDDLE EAR EFFUSION 1 0.0005
82 FAECES PALE 1 0.0004
83 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
84 SKIN ABRASION 2 0.0004
85 FAECES SOFT 3 0.0004
86 INTENTIONAL UNDERDOSE 3 0.0004
87 HEPATOMEGALY 4 0.0004
88 MUCOUS STOOLS 2 0.0004
89 HEPATIC ENZYME ABNORMAL 2 0.0004
90 HEPATOCELLULAR CARCINOMA 3 0.0004
91 HEPATOSPLENOMEGALY 1 0.0004
92 SCRATCH 4 0.0004
93 HEPATIC CIRRHOSIS 7 0.0004
94 BLOOD SODIUM INCREASED 1 0.0004
95 HEPATIC ENZYME INCREASED 25 0.0004
96 SUBDURAL HAEMORRHAGE 1 0.0004
97 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
98 THERAPEUTIC RESPONSE DELAYED 1 0.0004
99 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
100 BILIARY COLIC 1 0.0003
101 SPLENOMEGALY 4 0.0003
102 GROWTH RETARDATION 1 0.0003
103 VARICES OESOPHAGEAL 1 0.0003
104 LIVER FUNCTION TEST INCREASED 7 0.0003
105 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
106 CHOLANGITIS 2 0.0003
107 BILE DUCT STONE 1 0.0003
108 POTENTIATING DRUG INTERACTION 1 0.0003
109 HEPATIC FIBROSIS 1 0.0003
110 DEFAECATION URGENCY 2 0.0003
111 PRURITUS 109 0.0003
112 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
113 MACULOPATHY 1 0.0003
114 APPENDICECTOMY 1 0.0003
115 PRODUCT SUPPLY ISSUE 2 0.0003
116 RENAL TRANSPLANT 1 0.0003
117 GASTROINTESTINAL PAIN 3 0.0003
118 PROTEIN TOTAL DECREASED 1 0.0003
119 PRODUCT STORAGE ISSUE 1 0.0003
120 RHINOVIRUS INFECTION 1 0.0003
121 SKIN ODOUR ABNORMAL 1 0.0003
122 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
123 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
124 SLEEP TERROR 1 0.0002
125 HEPATIC PAIN 1 0.0002
126 VITAMIN D DECREASED 2 0.0002
127 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
128 IRON DEFICIENCY 1 0.0002
129 HEAVY MENSTRUAL BLEEDING 2 0.0002
130 DISEASE COMPLICATION 1 0.0002
131 YELLOW SKIN 1 0.0002
132 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
133 CHOLESTASIS 4 0.0002
134 INCORRECT DOSAGE ADMINISTERED 1 0.0002
135 FLUID INTAKE REDUCED 1 0.0002
136 MALABSORPTION 1 0.0002
137 BLOOD LACTIC ACID INCREASED 1 0.0002
138 DECREASED ACTIVITY 2 0.0002
139 COAGULOPATHY 3 0.0002
140 HEPATOTOXICITY 4 0.0002
141 MALNUTRITION 2 0.0002
142 PERIORBITAL SWELLING 1 0.0002
143 DIARRHOEA 113 0.0002
144 NEUROLOGICAL SYMPTOM 1 0.0002
145 LIVER FUNCTION TEST ABNORMAL 5 0.0002
146 PRODUCT LABEL CONFUSION 1 0.0002
147 HYPERCHLORHYDRIA 1 0.0002
148 SYMPTOM RECURRENCE 1 0.0002
149 HEPATIC FAILURE 5 0.0002
150 HEPATIC STEATOSIS 3 0.0002
151 PRE-EXISTING CONDITION IMPROVED 1 0.0002
152 BLOOD SODIUM DECREASED 3 0.0002
153 PRODUCT PREPARATION ISSUE 1 0.0002
154 ABDOMINAL PAIN UPPER 31 0.0002
155 TERMINAL STATE 1 0.0001
156 TREATMENT NONCOMPLIANCE 8 0.0001
157 AUTOIMMUNE HEPATITIS 1 0.0001
158 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
159 POOR QUALITY SLEEP 3 0.0001
160 FAECES DISCOLOURED 3 0.0001
161 GASTROENTERITIS 2 0.0001
162 HEPATIC FUNCTION ABNORMAL 5 0.0001
163 ACIDOSIS 1 0.0001
164 BOWEL MOVEMENT IRREGULARITY 1 0.0001
165 PROCEDURAL COMPLICATION 1 0.0001
166 PRODUCT USE COMPLAINT 2 0.0001
167 RENAL CYST 1 0.0001
168 TRICUSPID VALVE INCOMPETENCE 1 0.0001
169 TRANSPLANT REJECTION 1 0.0001
170 VIRAL INFECTION 4 0.0001
171 OFF LABEL USE 104 0.0001
172 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
173 LUNG INFILTRATION 1 0.0001
174 GASTROINTESTINAL INFECTION 1 0.0001
175 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
176 ANAL INCONTINENCE 1 0.0001
177 DEVELOPMENTAL DELAY 1 0.0001
178 HEPATIC ENCEPHALOPATHY 1 0.0001
179 APPENDICITIS 1 0.0001
180 PRODUCT PACKAGING ISSUE 1 0.0001
181 ACUTE RESPIRATORY FAILURE 2 0.0001
182 DIZZINESS POSTURAL 1 0.0001
183 PRODUCT DOSE OMISSION ISSUE 30 0.0001
184 THERAPY CHANGE 1 0.0001
185 KNEE OPERATION 1 0.0001
186 LABORATORY TEST ABNORMAL 3 0.0001
187 ABDOMINAL PAIN 23 0.0001
188 FEEDING DISORDER 2 0.0001
189 DRY THROAT 1 0.0001
190 HELICOBACTER INFECTION 1 0.0001
191 TRANSFUSION 1 0.0001
192 INCONTINENCE 1 0.0001
193 IRRITABLE BOWEL SYNDROME 2 0.0001
194 SKIN LACERATION 1 0.0001
195 CHOLELITHIASIS 3 0.0001
196 THERAPY NON-RESPONDER 4 0.0001
197 MITRAL VALVE INCOMPETENCE 1 0.0001
198 SCAB 1 0.0001
199 METASTASES TO LUNG 1 0.0001
200 HEPATIC CANCER 2 0.0001
201 PHARYNGITIS 1 0.0001
202 TOOTH EXTRACTION 1 0.0001
203 COLITIS 3 0.0001
204 HEPATITIS 2 0.0001
205 DIPLOPIA 2 0.0001
206 ORAL CANDIDIASIS 1 0.0001
207 TOOTH INFECTION 1 0.0001
208 PANCREATITIS 4 0.0001
209 PRODUCT TASTE ABNORMAL 1 0.0001
210 POLLAKIURIA 3 0.0001
211 INFLUENZA 8 0.0001
212 BLOOD TEST ABNORMAL 1 0.0001
213 FLATULENCE 4 0.0001
214 ACCIDENTAL UNDERDOSE 1 0.0001
215 DRUG INTERACTION 11 0.0001
216 PARAESTHESIA ORAL 1 0.0001
217 ASCITES 2 0.0001
218 LIVER DISORDER 3 0.0001
219 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
220 BLOOD POTASSIUM DECREASED 2 0.0001
221 ABDOMINAL DISCOMFORT 11 0.0001
222 INSURANCE ISSUE 1 0.0001
223 LYMPHOMA 1 0.0001
224 TENDONITIS 1 0.0001
225 DRUG LEVEL INCREASED 1 0.0001
226 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
227 DISEASE PROGRESSION 7 0.0001
228 SCAR 1 0.0001
229 ILLNESS 6 0.0001
230 INTENTIONAL PRODUCT MISUSE 5 0.0001
231 COLD SWEAT 1 0.0001
232 GASTROENTERITIS VIRAL 1 0.0001
233 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
234 MIDDLE INSOMNIA 1 0.0001
235 PRODUCT USE ISSUE 10 0.0001
236 DEHYDRATION 7 0.0001
237 INCREASED APPETITE 1 0.0001
238 DRUG INTOLERANCE 5 0.0001
239 HERNIA 1 0.0001
240 EAR PAIN 1 0.0001
241 IRRITABILITY 3 0.0000
242 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
243 PRODUCT ADMINISTRATION ERROR 1 0.0000
244 EATING DISORDER 1 0.0000
245 RETCHING 1 0.0000
246 VOMITING 22 0.0000
247 IMPAIRED WORK ABILITY 1 0.0000
248 PRODUCT DISPENSING ERROR 1 0.0000
249 MELAENA 1 0.0000
250 SEPSIS 5 0.0000
251 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
252 GASTROINTESTINAL DISORDER 4 0.0000
253 MUSCLE TWITCHING 1 0.0000
254 PERICARDIAL EFFUSION 1 0.0000
255 SLEEP DISORDER 3 0.0000
256 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
257 CONSTIPATION 9 0.0000
258 MENTAL IMPAIRMENT 1 0.0000
259 UNDERDOSE 3 0.0000
260 LIVER INJURY 1 0.0000
261 EPISTAXIS 3 0.0000
262 AGEUSIA 1 0.0000
263 ABDOMINAL PAIN LOWER 1 0.0000
264 HAEMATEMESIS 1 0.0000
265 WEIGHT DECREASED 11 0.0000
266 RESPIRATORY TRACT INFECTION 1 0.0000
267 ABDOMINAL DISTENSION 4 0.0000
268 DEAFNESS 1 0.0000
269 EAR INFECTION 1 0.0000
270 FREQUENT BOWEL MOVEMENTS 1 0.0000
271 SKIN LESION 1 0.0000
272 DRUG INEFFECTIVE 48 0.0000
273 HAEMATOCHEZIA 2 0.0000
274 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
275 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
276 INTENTIONAL DOSE OMISSION 1 0.0000
277 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
278 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
279 RENAL INJURY 1 0.0000
280 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
281 THERAPEUTIC RESPONSE DECREASED 2 0.0000
282 EPILEPSY 1 0.0000
283 FEELING HOT 2 0.0000
284 HOSPITALISATION 5 0.0000
285 EXPOSURE DURING PREGNANCY 2 0.0000
286 DRUG-INDUCED LIVER INJURY 1 0.0000
287 HYPOTHYROIDISM 1 0.0000
288 WEIGHT INCREASED 7 0.0000
289 FUNGAL INFECTION 1 0.0000
290 SKIN DISORDER 1 0.0000
291 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
292 SINUSITIS 3 0.0000
293 HAEMATURIA 1 0.0000
294 HAEMORRHAGE 3 0.0000
295 CRYING 1 0.0000
296 C-REACTIVE PROTEIN INCREASED 1 0.0000
297 AGITATION 2 0.0000
298 INSOMNIA 7 0.0000
299 NAUSEA 20 0.0000
300 BLINDNESS 1 0.0000
301 RECTAL HAEMORRHAGE 1 0.0000
302 SEPTIC SHOCK 1 0.0000
303 DRY SKIN 3 0.0000
304 INCORRECT DOSE ADMINISTERED 5 0.0000
305 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
306 OROPHARYNGEAL PAIN 2 0.0000
307 DECREASED APPETITE 5 0.0000
308 CARDIAC DISORDER 2 0.0000
309 ANAEMIA 4 0.0000
310 BLOOD GLUCOSE DECREASED 1 0.0000
311 CONTUSION 2 0.0000
312 HYPOGLYCAEMIA 1 0.0000
313 ALOPECIA 4 0.0000
314 DYSPEPSIA 2 0.0000
315 PYREXIA 7 0.0000
316 DRY EYE 1 0.0000
317 MUSCULOSKELETAL PAIN 1 0.0000
318 DEPRESSED MOOD 1 0.0000
319 OEDEMA 1 0.0000
320 MEDICATION ERROR 1 0.0000
321 BLISTER 1 0.0000
322 BONE PAIN 1 0.0000
323 NASAL CONGESTION 1 0.0000
324 ILL-DEFINED DISORDER 1 0.0000
325 PLEURAL EFFUSION 1 0.0000
326 MUSCLE SPASMS 3 0.0000
327 RHINORRHOEA 1 0.0000
328 SKIN BURNING SENSATION 1 0.0000
329 UNEVALUABLE EVENT 1 0.0000
330 ACUTE KIDNEY INJURY 2 0.0000
331 PERIPHERAL SWELLING 2 0.0000
332 HEADACHE 8 0.0000
333 DRY MOUTH 1 0.0000
334 URTICARIA 2 0.0000
335 RENAL IMPAIRMENT 1 0.0000
336 FATIGUE 9 0.0000
337 PRODUCT STORAGE ERROR 1 0.0000
338 ADVERSE DRUG REACTION 1 0.0000
339 SUICIDAL IDEATION 1 0.0000
340 ADVERSE EVENT 1 0.0000
341 COUGH 3 0.0000
342 ATRIAL FIBRILLATION 1 0.0000
343 HEART RATE INCREASED 1 0.0000
344 SOMNOLENCE 2 0.0000
345 CONDITION AGGRAVATED 3 0.0000
346 HAEMOGLOBIN DECREASED 1 0.0000
347 DEATH 8 0.0000
348 PNEUMONIA 3 0.0000
349 MALAISE 4 0.0000
350 THROMBOCYTOPENIA 1 0.0000
351 ASTHMA 1 0.0000
352 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
353 FEELING ABNORMAL 2 0.0000
354 OEDEMA PERIPHERAL 1 0.0000
355 VISUAL IMPAIRMENT 1 0.0000
356 ASTHENIA 3 0.0000
357 LOSS OF CONSCIOUSNESS 1 0.0000
358 VISION BLURRED 1 0.0000
359 ANXIETY 2 0.0000
360 INFECTION 1 0.0000
361 HYPOAESTHESIA 1 0.0000
362 BLOOD PRESSURE INCREASED 1 0.0000
363 PARAESTHESIA 1 0.0000
364 CONFUSIONAL STATE 1 0.0000
365 TREMOR 1 0.0000
366 CEREBROVASCULAR ACCIDENT 1 0.0000
367 URINARY TRACT INFECTION 1 0.0000
368 COVID-19 1 0.0000
369 HYPERSENSITIVITY 1 0.0000
370 BLOOD GLUCOSE INCREASED 1 0.0000
371 GAIT DISTURBANCE 1 0.0000
372 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
373 PAIN 3 0.0000
374 ARTHRALGIA 2 0.0000
375 DEPRESSION 1 0.0000
376 BACK PAIN 1 0.0000
377 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
378 DIZZINESS 2 0.0000
379 FALL 1 0.0000